WKQ-0014215

英文名稱：Fibrinogen γ-chain fragment

英文別名：L-Valine, N-[N-[N-[N-(N2-L-lysyl-L-glutaminyl)-L-alanyl]glycyl]-L-α-aspartyl]-;L-Lysyl-L-glutaminyl-L-alanylglycyl-L-α-aspartyl-L-valine;12: PN: JP2010159217 SEQID: 12 unclaimed protein;12: PN: JP2011139839 PAGE: 11 unclaimed sequence;13: PN: JP2011229661 PAGE: 9 unclaimed sequence;14: PN: WO2009120895 SEQID: 14 claimed sequence;1: PN: WO2011056685 PAGE: 63 unclaimed sequence;1: PN: WO2013069661 SEQID: 1 unclaimed sequence;1: PN: WO2017072759 SEQID: 1 claimed sequence;20: PN: US20020198360 SEQID: 1 unclaimed sequence;29: PN: WO2010123945 SEQID: 4 unclaimed protein;2: PN: WO0045856 PAGE: 199 claimed protein;2: PN: WO2004072289 SEQID: 10 unclaimed sequence;2: PN: WO2012124998 SEQID: 4 claimed protein;31: PN: WO2010005513 SEQID: 30 claimed protein;3: PN: WO2017106333 SEQID: 3 claimed protein;40: PN: US20140004158 SEQID: 41 unclaimed sequence;49: PN: WO2010114143 SEQID: 49 claimed sequence;4: PN: US20060029544 PAGE: 7 unclaimed sequence;4: PN: US20110052695 SEQID: 4 unclaimed protein;4: PN: US20110189292 SEQID: 4 unclaimed sequence;4: PN: US6521211 PAGE: 151 claimed protein;4: PN: WO2004108888 SEQID: 5 unclaimed sequence;55: PN: US20110311490 SEQID: 14 claimed sequence;58: PN: WO2011021524 SEQID: 58 unclaimed protein;5: PN: DE10119096 PAGE: 10 claimed sequence;6: PN: WO2019117976 SEQID: 6 claimed protein;7: PN: SG10201703850 PAGE: 27 claimed sequence;88: PN: WO03072542 SEQID: 93 claimed sequence;8: PN: WO2016163828 PAGE: 21 claimed sequence;98: PN: US20110129531 SEQID: 4 claimed sequence;Fibrinogen γ-chain fragment;

分子式：C25H44N8O10

分子量：616.66

CAS號：80755-87-9

純度：HPLC≥98%

沸點：1174.8±65.0 °C | Condition: Press: 760 Torr

密度：1.310±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr

酸系度數(shù)：3.20±0.10 | Condition: Most Acidic Temp: 25 °C

儲存條件：-20℃，干燥、避光、密封

規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應客戶需求包裝

供應單位：四川省維克奇生物科技有限公司

供應電話：028-81700200/4008005713

四川省維克奇生物科技有限公司生產(chǎn)中藥類標準品和天然植物有效單體，主打中藥對照品/標準品/天然植物有效單體，化學合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關注！ 新批次有現(xiàn)貨，歡迎咨詢。